Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by TMAN2019on Jun 29, 2020 6:45pm
195 Views
Post# 31205409

RE:RE:RE:Hepalink NR includes RVX

RE:RE:RE:Hepalink NR includes RVX

G1945V,  i noticed from hepalink USA and rvx NR, almost same wording used , but hepalink USA especially says at the end of the NR for RVX-208, 

Would you think HL USA , no more milestone payment but buying out RVX-208 and RVX would keep their other product in the pipeline? They are liscencing in China, but from their other "product" they have a distribution in more Countries. Maybe that is the route they want to persue with RVX-208 instead issuing payment for each Country just buy all of it?  Maybe talks in the background is other major Shareholders don't want to give it up at lower price, more Risk now but cheaper... 

Lots of questions, RVX needs a partner with lots of $$$ for BETONMACE2, I think this summer will be busier than  other years. 


it was nice HL NR to see RVX included  in their NR!


 

Bullboard Posts